You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.

Tag:

TNBC x

Doctor wearing a lab coat and mask holding a clip board speaks to a patient

At this year’s virtual San Antonio Breast Cancer Symposium (SABCS)—the world’s largest scientific conference dedicated to breast cancer—investigators reported a number of key findings from trials testing immunotherapies and targeted agents for triple-negative breast cancer (TNBC), an aggressive f

Triple negative breast cancer (TNBC) accounts for approximately 15 percent of all breast cancers.

When a person is diagnosed with breast cancer, one of the first things to determine is what “subtype” of breast cancer it is.

When Rochelle Barr first heard the words “triple negative breast cancer,” she was optimistic about her prognosis. After all, in the medical world, testing negative is usually considered a good thing.

Dr. Loi received her first BCRF research grant in 2014, but was no stranger to the BCRF researcher community.

In this two-part series presented in conjunction with Triple Negative Breast Cancer Day (March 3, 2015) we are sharing a conversation with BCRF grantee, Dr.

In this two-part series presented in conjunction with Triple Negative Breast Cancer Day (March 3, 2015) we are sharing a conversation with BCRF grantee, Dr.